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Abstract 
Background: Several plant diterpenes have important biological properties. Among them, forskolin is a complex 
labdane-type diterpene whose biological activity stems from its ability to activate adenylyl cyclase and to elevate 
intracellular cAMP levels. As such, it is used in the control of blood pressure, in the protection from congestive heart 
failure, and in weight-loss supplements. Chemical synthesis of forskolin is challenging, and production of forskolin in 
engineered microbes could provide a sustainable source. To this end, we set out to establish a platform for the pro-
duction of forskolin and related epoxy-labdanes in yeast.
Results: Since the forskolin biosynthetic pathway has only been partially elucidated, and enzymes involved in 
terpene biosynthesis frequently exhibit relaxed substrate specificity, we explored the possibility of reconstructing 
missing steps of this pathway employing surrogate enzymes. Using CYP76AH24, a Salvia pomifera cytochrome P450 
responsible for the oxidation of C-12 and C-11 of the abietane skeleton en route to carnosic acid, we were able to pro-
duce the forskolin precursor 11β-hydroxy-manoyl oxide in yeast. To improve 11β-hydroxy-manoyl oxide production, 
we undertook a chassis engineering effort involving the combination of three heterozygous yeast gene deletions 
(mct1/MCT1, whi2/WHI2, gdh1/GDH1) and obtained a 9.5-fold increase in 11β-hydroxy-manoyl oxide titers, reaching 
21.2 mg L−1.
Conclusions: In this study, we identify a surrogate enzyme for the specific and efficient hydroxylation of manoyl 
oxide at position C-11β and establish a platform that will facilitate the synthesis of a broad range of tricyclic 
(8,13)-epoxy-labdanes in yeast. This platform forms a basis for the heterologous production of forskolin and will 
facilitate the elucidation of subsequent steps of forskolin biosynthesis. In addition, this study highlights the usefulness 
of using surrogate enzymes for the production of intermediates of complex biosynthetic pathways. The combination 
of heterozygous deletions and the improved yeast strain reported here will provide a useful tool for the production of 
numerous other isoprenoids.
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Background
Plant natural products have found numerous applica-
tions in fragrances, flavors or pharmaceuticals, but the 
exploitation of many of these compounds is hampered 
by limited availability or seasonal variation of the raw 
materials. Reconstruction of natural product biosyn-
thetic pathways in engineered microbes can provide a 
sustainable alternative and has so far been successful in 
providing access to important industrial compounds (e.g. 
artemisinin, resveratrol, vanillin [1–3]). Among the plant 
natural products with industrial application, terpenes (or 
isoprenoids) form the largest and more diverse group. 
Terpenes are synthesized by the successive addition 
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of the 5-carbon isoprene building block, giving rise to 
classes of compounds with increasing skeletal size, such 
as hemiterpenes (C5), monoterpenes (C10), sesquiterpe-
nes (C15), and diterpenes (C20) (Fig. 1).
Within the diterpene class, the superfamily of labdane-
related diterpenes comprises more than 7000 members 
and is characterized by a basic decalin core [4]. Their 
biosynthesis requires the cyclization of geranylgeranyl 
diphosphate (GGPP), by a class II diterpene synthase 
(diTPS), to a labdane-type diphosphate (e.g. (+)-copalyl 
diphosphate ((+)-CPP) or 8-hydroxy-CPP (8OH-CPP)), 
which is subsequently taken up by a class I diTPS to gen-
erate the basic diterpene skeleton (Fig.  1). Through the 
action of decorating enzymes, such as cytochrome P450s 
(CYPs), these basic labdane-type skeletons are converted 
to a diverse array of highly complex molecules [4]. Several 
labdane-type diterpenes, such as tanshinones, carnosic 
acid, and forskolin, display potent biological activities. 
Tanshinones are isolated from the roots of Salvia miltio-
rrhiza and exhibit strong antioxidant and anti-inflamma-
tory activities, and cardiovascular and cerebrovascular 
therapeutic effects [5–8]. Carnosic acid (14) and carnosol 
are well known antioxidants produced in rosemary and 
Salvia spp., active as anti-adipogenic [9] and anticancer 
agents [10, 11]. Forskolin (6) is a complex heterocyclic lab-
dane diterpene produced in the root cork cells of Coleus 
forskohlii plant [12]. By activating adenylyl cyclase, it 
increases the intracellular cAMP levels and acts as a posi-
tive inotropic agent and a vaso- and broncho-dilator [13–
17]. Forskolin and its derivatives have found application 
Fig. 1 Schematic representation of isoprenoid biosynthesis via the mevalonic acid pathway. The mevalonate pathway provides the substrates for 
the different terpene classes [dimethylallyl diphosphate (DMAPP) for hemiterpenes (C5), geranyl diphosphate (GPP) for monoterpenes (C10), farnesyl 
diphosphate (FPP) for sterols, sesquiterpenes (C15) and triterpenes (C30), geranylgeranyl diphosphate (GGPP) for diterpenes (C20) and carotenoids 
(C40)]. Labdane-type diterpene biosynthesis from GGPP, via 8OH-CPP, is described using manoyl oxide as the example. Whi2p, previously identified 
as positive genetic interactor of HMG2 [38], and pathways competing for substrates involved in terpene biosynthesis, such as the mitochondrial 
fatty acid biosynthesis pathway or glutamate biosynthesis, are also indicated. Enzyme names correspond to the S. cerevisiae proteins. Steps down-
regulated in this study by heterozygous deletion of the corresponding gene are indicated by gray arrows
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in weight-loss supplements [18, 19], in the treatment of 
open angle glaucoma [20], in the control of blood pressure 
[21], and in the protection from congestive heart failure 
[22]. Enantioselective chemical synthesis of forskolin has 
not yet been successful, calling for the application of bio-
technological methods for its production. However, the 
forskolin biosynthetic pathway has only been partially elu-
cidated. The first steps are believed to involve the forma-
tion of (13R)-manoyl oxide (3) from GGPP (1), through 
8OH-CPP (2), and the enzymes involved in these reac-
tions have been identified and characterized [12]. The 
highly oxygenated structure of forskolin requires the oxi-
dation of five different carbon atoms of the manoyl oxide 
skeleton and the acetylation of the resulting 7β-OH group. 
One of the early events in this process likely involve oxi-
dation of manoyl oxide at position C-11, since 11-oxo-
manoyl oxide (5) (Fig.  2) was isolated from C. forskohlii 
roots [23, 24], but a catalytic activity responsible for this 
reaction has not yet been identified.
We recently established a “plug-and-play” platform to 
facilitate the reconstruction of the diversity of terpenes 
in yeast [25]. This approach revealed that class I diTPSs 
and related CYPs frequently exhibit significant substrate 
promiscuity, a property that can be exploited to provide 
surrogate enzymatic activities for orphan biosynthetic 
steps. In the process of biosynthetic pathway elucidation, 
a Synthetic Biology approach taking advantage of surro-
gate enzymes for the production of putative precursors of 
molecules of interest can serve as a useful tool. Produc-
tion of intermediates or precursors in microbial “chassis”, 
in titers that enable facile isolation and purification of 
these compounds, can yield complex substrates for activ-
ity screening using in vitro assays or coupled in vivo plat-
forms, greatly speeding up the full process [26]. Here, we 
apply such an approach in the production of the forskolin 
precursor 11β-hydroxy-manoyl oxide, taking advantage 
of two promiscuous enzymes from S. pomifera: one class 
I diTPS that is normally responsible for the conversion 
Fig. 2 Proposed biosynthetic pathway of forskolin and carnosic acid. Both pathways begin from the common diterpene precursor GGPP (1). In C. 
forskohlii, a class II diTPS converts GGPP to 8OH-CPP (2), which is then taken up by a class I enzyme, to form manoyl oxide (3). This, in turn, becomes 
oxidized at several positions (C-1, C-6, C-7, C-11), presumably by the action of specific CYPs, and eventually O-acetylated at the C-7 hydroxy to 
generate forskolin (6). 11β-hydroxy-manoyl oxide (4) and 11-oxo-manoyl oxide (5) are believed to be the first steps in this mechanism, although the 
enzyme(s) catalyzing these reactions in C. forskohlii have not yet been identified. In S. pomifera, GGPP is converted to CPP (7) and then to miltiradi-
ene (8) by corresponding class II (CPP synthase; CDS) and class I (Miltiradiene synthase; SpMilS) diTPSs. Miltiradiene is non-enzymatically converted 
to abietatriene (11), the substrate of CYP76AH24. CYP76AH24 catalyzes two successive oxidation events, one on C-12 of abietatriene producing fer-
ruginol (12), and a second one on C-11 of ferruginol producing 11-hydroxy-ferruginol (13). When provided with miltiradiene, in vitro or in yeast cells, 
CYP76AH24 catalyzes a two step oxidation leading to 11-keto-miltiradiene (10), via 11-hydroxy-miltiradiene (9) [26]. The dashed box encloses the 
reactions catalyzed by CYP76AH24. CYP76AK6 takes up 11-hydroxy-ferruginol to catalyze a three step oxidation leading to carnosic acid (14) [26]. 
The promiscuous class I diTPSs, SpMilS, can also accept 8OH-CPP (2) to produce manoyl oxide (3) [25] To reconstruct the first steps of the forskolin 
biosynthetic pathway in yeast, CcCLS was used to produce 8OH-CPP, SpMilS was employed to convert 8OH-CPP to manoyl oxide, and CYP76AH24 
was exploited to oxidize manoyl oxide (3) to 11β-hydroxy-manoyl oxide (4)
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of (+)-CPP to miltiradiene [27], a key intermediate in 
the biosynthesis of carnosic acid-related diterpenes, and 
one CYP targeting C-12 and C-11 of the abietatriene 
skeleton [26]. Combined with a set of heterozygous yeast 
gene deletions (MCT1, WHI2, GDH1) aiming to improve 
manoyl oxide availability, we achieved a fourfold increase 
in manoyl oxide conversion efficiency and a 9.5-fold 
increase in 11β-hydroxy-manoyl oxide titers, reaching 
21.2 mg L−1. This approach sets the basis for the heter-
ologous production of forskolin in yeast and provides a 
tool for the elucidation of subsequent steps of forskolin 
biosynthesis, such as hydroxylation at positions C-1, C-6, 
C-7 or C-9.
Results and discussion
Establishing manoyl oxide production in yeast using a 
surrogate terpene synthase
Due to the so far limited knowledge of the final steps of 
its biosynthetic pathway, we set out to reconstruct for-
skolin biosynthesis in yeast using surrogate diTPS and 
CYP activities. In our previous work, we discovered that 
several class I diTPSs examined were able to accept alter-
native substrates and to yield different products with 
similar efficiency [25]. One such example was S. pomif-
era miltiradiene synthase (SpMilS), an enzyme believed 
to accept (+)-CPP as its physiological substrate to pro-
duce miltiradiene. Miltiradiene is a common precursor 
in the biosynthesis of tanshinones and carnosic acid-
related diterpenes and several miltiradiene synthases 
have been reported in different organisms, including S. 
miltiorrhiza, S. pomifera, S. fruticosa and Rosmarinus 
officinalis [27–30]. When SpMilS is provided with the 
8-hydroxy form of CPP, 8OH-CPP, it produces primar-
ily manoyl oxide [25]. Taking advantage of this observa-
tion, we exploited SpMilS to set up an efficient manoyl 
oxide-producing yeast system in strain AM119 (Table 1). 
AM119 was selected because it presents a favorable chas-
sis for the development of a modular platform that can 
incorporate additional oxidation steps. In yeast, over-
production of exogenous CYPs frequently leads to poor 
oxidation efficiency due to heme depletion [31]. Increas-
ing the levels of the limiting enzyme of the heme biosyn-
thetic pathway, encoded by the HEM3 gene, was found to 
overcome heme depletion and to improve bioconversion 
[31]. Thus, to provide a chassis amenable to the incorpo-
ration of multiple CYP oxidation events, strain AM119 
was developed by chromosomal integration of the HEM3 
gene under the control of the strong PTDH3 promoter in 
the 3′-UTR of the FLO5 locus of strain AM102 [26]. In 
order to establish manoyl oxide production in AM119, 
in addition to SpMilS, the fusion between the Cistus 
creticus 8OH-CPP synthase (CcCLS) and a GGPP-pro-
ducing yeast Erg20p mutant (Erg20p(F96C)) was also 
expressed to provide high levels of the 8OH-CPP precur-
sor (Fig.  3a). Under these conditions, the manoyl oxide 
titer at the end of shake-flask batch cultivation reached 
41 mg L−1 of yeast culture. The reported titer for manoyl 
oxide production using the C. forskolii manoyl oxide syn-
thase is 10 mg L−1 [33].
Oxidation of manoyl oxide by CYP76AH24
Recently, we discovered CYP76AH24 from S. pomifera 
as an enzyme responsible for the oxidation of C-12 of 
abietatriene to produce ferruginol and the subsequent 
oxidation of C-11 of ferruginol to yield 11-hydroxy-
ferruginol (Fig.  2), two important intermediates in the 
carnosic acid biosynthetic pathway. When provided 
with miltiradiene, CYP76AH24 catalyzed two succes-
sive oxidation events on C-11, giving rise to 11-keto-
miltiradiene (Fig. 2; [26]). Thus, CYP76AH24 appears to 
exhibit relatively relaxed substrate selectivity, being able 
to accept several structurally related molecules and to 
catalyze their oxidation at C-12 or C-11. Assuming that 
additional compounds with similar structure may also be 
oxidized by CYP76AH24, we decided to investigate its 
ability to catalyze conversion of manoyl oxide to related 
oxidized structures. Manoyl oxide-producing AM119 
yeast cells were engineered to express CYP76AH24 and 
poplar CPR2 [33] from the bidirectional vector pESC-
Leu under the PGAL10 and PGAL1 promoters, respectively 
Table 1 List of S. cerevisiae strains used
Strain Genotype Source
AM119 Mat a/α, PGal1-HMG2(K6R)::HOX2, ura3, trp1, his3, PTDH3-HMG2(K6R)X2-::leu2 ERG9/erg9, ubc7/UBC7, ssm4/SSM4,  
PTDH3-HEM3-FLO5
Ref. [26]
AM119-1 Mat a/α, PGal1-HMG2(K6R)::HOX2, ura3, trp1, his3, PTDH3-HMG2(K6R)X2-::leu2 ERG9/erg9, ubc7/UBC7, ssm4/SSM4,  
PTDH3-HEM3-FLO5, PTDH3-CcGGPPS1-FLO8
This study
AM119-2 Mat a/α, PGal1-HMG2(K6R)::HOX2, ura3, trp1, his3, PTDH3-HMG2(K6R)X2-::leu2 ERG9/erg9, ubc7/UBC7, ssm4/SSM4, mct1/MCT1, 
PTDH3-HEM3-FLO5, PTDH3-CcGGPPS1-FLO8
This study
AM119-3 Mat a/α, PGal1-HMG2(K6R)::HOX2, ura3, trp1, his3, PTDH3-HMG2(K6R)X2-::leu2 ERG9/erg9, ubc7/UBC7, ssm4/SSM4, mct1/MCT1, 
whi2/WHI2, PTDH3-HEM3-FLO5, PTDH3-CcGGPPS1-FLO8
This study
AM119-4 Mat a/α, PGal1-HMG2(K6R)::HOX2, ura3, trp1, his3, PTDH3-HMG2(K6R)X2-::leu2 ERG9/erg9, ubc7/UBC7, ssm4/SSM4, mct1/MCT1, 
whi2/WHI2, gdh1/GDH1, PTDH3-HEM3-FLO5, PTDH3-CcGGPPS1-FLO8
This study
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(Fig.  3b). GC–MS analysis of the dodecane extracts of 
the corresponding cultures revealed one new peak com-
pared to the empty vector control, likely corresponding 
to a manoyl oxide oxidation product (Fig. 4a). To exam-
ine whether additional manoyl oxide oxidation products 
are formed, which are either retained by yeast cells or 
inefficiently volatilized during GC–MS analysis, yeast 
cultures were extracted with pentane and the extracts 
were derivatized with Sylon-HTP (Sigma-Aldrich) prior 
to analysis. No additional peak was detected, suggesting 
that CYP76AH24 likely catalyzes the synthesis of one 
main oxidized form of manoyl oxide.
In order to identify the structure of the new com-
pound, a large scale yeast culture (1  L) producing the 
unknown hydroxy-manoyl oxide derivative was estab-
lished and the dodecane extract was fractionated 
and analyzed as described in the “Methods” section. 
Analysis of its NMR spectra revealed the identity of 
the new product as 11β-hydroxy-manoyl oxide (Addi-
tional file 1: Figs. S1 and S2, Table S2). To confirm that 
11β-hydroxy-manoyl oxide is indeed the product of 
the CYP76AH24-catalyzed reaction and not the result 
of an in vivo bioconversion event, the enzymatic activ-
ity of CYP76AH24 was analyzed in  vitro using puri-
fied yeast microsomal fractions in the presence of 
manoyl oxide and NADPH co-factor. A single prod-
uct with retention time and mass spectrum match-
ing that of purified 11β-hydroxy-manoyl oxide was 
detected (Fig.  4b–d). Kinetic analysis using the yeast 
microsomal preparation of CYP76AH24 revealed that 
this reaction occurs with high efficiency compared 
to the oxidation of C-11 of miltiradiene or ferrugi-
nol by CYP76AH24 (kcat/KM  =  315  ×  103  min−1  M−1 
for manoyl oxide vs. 133 × 103 min−1 M−1 for ferrugi-
nol and 29.3 ×  103  min−1  M−1 for miltiradiene; Fig.  5; 
Table 2).
Fig. 3 Diagrammatic illustration of configuration of the yeast 
platform for the production manoyl oxide and 11β-hydroxy-manoyl 
oxide. a The fusion between the class II diTPS, CcCLS, responsible for 
8OH-CPP formation and the yeast variant Erg20p(F96C), engineered 
to synthesize GGPP, under uracil selection (U) was co-expressed in 
yeast cells with the class I diTPS, SpMilS, under histidine (H) selection, 
for the production of manoyl oxide. b Introduction of CYP76AH24 in 
the above system, under leucine (L) selection, enabled oxidation of 
manoyl oxide to 11β-hydroxy-manoyl oxide
Fig. 4 Formation of 11β-hydroxy-manoyl oxide by CYP76AH24. a 
Expression of CYP76AH24 in manoyl oxide-producing yeast cells 
resulted in the production of a new compound, which after isolation 
and structural analysis was identified as 11β-hydroxy-manoyl oxide. 
b GC–MS chromatogram of the products of an in vitro reaction using 
microsomal CYP76AH24 protein, manoyl oxide as substrate and 
NADPH as co-factor. A preparation of yeast microsomal membranes 
from a strain that expressed only CPR2 is used as control. Produc-
tion of 11β-hydroxy-manoyl oxide was confirmed by comparison of 
retention time and mass spectrum with purified compound. c Mass 
spectrum of 11β-hydroxy-manoyl oxide standard (isolated from engi-
neered yeast cells and characterized by NMR spectroscopy). d Mass 
spectrum of 11β-hydroxy-manoyl oxide produced by CYP76AH24 in 
an in vitro reaction
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Chassis engineering to improve manoyl oxide 
and 11β‑hydroxy‑manoyl oxide production
Titers of 11β-hydroxy-manoyl oxide produced by AM119 
cells reached 2.3 mg L−1, indicating a 5.3 % efficiency of 
manoyl oxide conversion (as estimated by the ratio of 
11β-hydroxy-manoyl oxide titer to the sum of manoyl 
oxide and 11β-hydroxy-manoyl oxide titres). One fac-
tor limiting the efficiency of manoyl oxide oxidation 
may be a relatively low intracellular concentration of 
manoyl oxide. The estimated Michaelis–Menten con-
stant (KM = 11.6 μM) for the oxidation of manoyl oxide 
by CYP76AH24 suggests that if the intracellular concen-
tration of manoyl oxide is in the low micromolar range, 
the enzyme will not function at maximum efficiency. 
Thus, increasing the yield of manoyl oxide synthesis 
may help improving the efficiency of conversion. To this 
end, a metabolic engineering effort aiming to improve 
strain AM119 as a chassis for diterpene production was 
undertaken.
Incorporation of a plant GGPP synthase—Initially, 
we aimed to improve the endogenous GGPP pool by 
constitutive expression of the C. creticus GGPP syn-
thase (CcGGPPS) from a chromosomally integrated 
copy. The mature form of CcGGPPS was incorporated 
in the 3′-UTR FLO8 locus of AM119 strain, under the 
control of the PTDH3 constitutive promoter, generat-
ing strain AM119-1. No significant difference in either 
manoyl oxide or 11β-hydroxy-manoyl oxide titers was 
observed, suggesting that the Erg20p mutant used for 
GGPP production is providing sufficient levels of GGPP 
for 8OH-CPP synthesis and that this step is not limiting 
the pathway.
Heterozygous deletion of MCT1—Isoprenoid biosyn-
thesis in yeast proceeds mainly through the mevalonic 
acid pathway, which greatly relies on the availability of 
acetyl-CoA precursor. The acetyl-CoA pool is drained 
by competing pathways, such as ethanol production or 
membrane lipid and fatty acid biosynthesis, which divert 
acetyl-CoA from isoprenoid biosynthesis. One such 
pathway that competes for the availability of acetyl-CoA 
is the mitochondrial fatty acid biosynthesis pathway (or 
octanoyl-ACP pathway), which is responsible for the 
synthesis of lipoic acid and other mitochondrial mem-
brane lipids [34]. This pathway is highly conserved and 
completely independent of the yeast cytosolic fatty acid 
synthase apparatus. In yeast, the second enzyme in this 
pathway is the malonyl-CoA:ACP transferase Mct1p 
(Fig.  1). Downregulation of MCT1 is expected to redi-
rect the acetyl-CoA substrate from fatty acid biosynthe-
sis towards the mevalonate pathway and subsequently 
terpene biosynthesis. However, deletion of MCT1 has 
been reported to result in a respiratory-deficient phe-
notype and small rudimentary mitochondria [35]. Dele-
tion of one of the two alleles of a certain gene in a yeast 
diploid strain results in a decrease in the levels of the 
corresponding proteins by approximately 50  % [36]. To 
alleviate potential negative effects on cellular growth 
and viability caused by complete deletions, we previously 
reported the combination of monoallelic gene deletions 
as an efficient alternative which allowed the develop-
ment of improved yeast strains for the production of the 
sesquiterpene β-caryophyllene [37]. Heterozygous dele-
tion mutant yeast strains are stable and maintain their 
improved characteristic over time [37]. To downregulate 

































Fig. 5 Steady-state kinetic analysis of the oxidation of manoyl oxide 
by CYP76AH24. The enzymatic activity of CYP76AH24 was evaluated 
using varying concentration (1–75 μM) of manoyl oxide substrate and 
80 pmol of enzyme. The produced 11β-hydroxy-manoyl oxide was 
quantified by CG–MS analysis using purified compound as standard. 
Quantification of CYP76AH24 enzyme concentration was performed 
by measuring the binding of CO to the reduced form of the purified 
enzyme (450 nm peak), according to [47]. The differential spectrum of 
the CO-treated enzyme preparation is shown in the inset
Table 2 CYP76AH24 kinetic parameters with different substrates
Substrate KM (μM) kcat (min
−1) kcat/KM (×103 min−1 M−1) Source
Manoyl oxide 11.6 ± 1.06 3.65 ± 0.12 315 This study
Ferruginol 45.84 ± 9.37 6.11 ± 0.45 133 Ref. [26]
Miltiradiene 72.63 ± 43.19 1.97 ± 0.72 27.1 Ref. [26]
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the deleterious effects of complete MCT1 elimination, 
only one of the two MCT1 alleles was deleted in strain 
AM119-1 to give rise to strain AM119-2 (Table 1). Hete-
rozygous MCT1 deletion improved 11β-hydroxy-manoyl 
oxide production by over twofold, reaching titers of 
5.8 mg L−1 and boosted manoyl oxide conversion rate to 
10.2 % (Fig. 6).
Heterozygous deletion of WHI2–Whi2p is a cytoplasmic 
scaffold protein required, together with its partner Psr1, 
for the proper activation of the general stress response. 
WHI2 was identified as a positive genetic interactor of 
HMG2 [38] and the heterozygous deletion whi2/WHI2 
was previously found to strongly synergize with 
ubc7/UBC7 (already present in the AM119 background) 
in enhancing sesquiterpene production [37]. Heterozy-
gous deletion of WHI2 (whi2/WHI2) in the AM119-2 
background generated strain AM119-3. In this chassis, 
11β-hydroxy-manoyl oxide production increased by 83 % 
to 10.6 mg L−1, while manoyl oxide conversion reached 
14.2 % (Fig. 6).
GDH1 deletion—NADP(+)-dependent glutamate 
dehydrogenase 1 (Gdh1p) synthesizes glutamate from 
ammonia and α-ketoglutarate (Fig.  1). A computa-
tional approach identified GDH1 as a gene the deletion 
of which could improve carbon flux through the meva-
lonate pathway, by increasing the pool of NADPH avail-
able for Hmg1p and Hmg2p [39]. Deletion of GDH1 in 
a haploid strain increased production of the sesquiter-
pene cubebol by 85  %. However, GDH1 deletion also 
caused a significant decrease in the growth rate [39]. To 
avoid possible growth inhibition, a heterozygous GDH1 
deletion strain, AM119-4, was derived from AM119-3 
(Table  1). When tested for 11β-hydroxy-manoyl oxide 
production, AM119-4 was 2 times more efficient than 
AM119-3, yielding 21.9  mg  L−1 (Fig.  6), without any 
detectable growth retardation. The combination of the 
three heterozygous deletions (mct1/MCT1, whi2/WHI2, 
gdh1/GDH1) lead to an overall 9.5-fold increase of 
11β-hydroxy-manoyl oxide titer over the base strain 
(AM119), and a fourfold improvement of manoyl oxide 
conversion (Fig. 6).
Conclusions
Aiming to identify surrogate enzymes for the heterolo-
gous biosynthesis of forskolin, we identified CYP76AH24 
as an enzyme that specifically catalyzes the introduc-
tion of one oxygen atom at the C-11β position of manoyl 
oxide to form the corresponding alcohol. An enzymatic 
activity capable of catalyzing this step is reported here for 
the first time. Further oxidation of 11β-hydroxy-manoyl 
oxide at the same position will generate the 11-oxo func-
tionality present in forskolin. The efficiency (kcat/KM) of 
manoyl oxide oxidation by CYP76AH24 is high and com-
parative to the oxidation of C-11 of ferruginol, one of the 
presumed in planta substrates of CYP76AH24 (Table 2). 
The use of surrogate enzymes has also proved to be an 
efficient method for the production of manoyl oxide. The 
overall performance of the platform using SpMilS as the 
manoyl oxide synthase compares favorably to the pub-
lished titers of manoyl oxide achieved using the corre-
sponding C. forskohlii enzyme in Escherichia coli and in 
Synechocystis sp. PCC 6803 (40–100 vs. 10 mg L−1 in [33] 
and 0.46 mg L−1 in [40, 41], respectively).
Examination of the efficiency of the oxidation of manoyl 
oxide in yeast reveals that as the manoyl oxide titer 
increases, so does the efficiency of conversion of manoyl 
oxide to 11β-hydroxy-manoyl oxide (Fig.  6b). This sug-
gests that at conditions where manoyl oxide production 
rates are low, most manoyl oxide does not accumulate 
Fig. 6 Optimization of 11β-hydroxy-manoyl oxide production in 
yeast cells. a Bar chart depicting the titers of manoyl oxide and 
11β-hydroxy-manoyl oxide obtained using the different strains 
developed in this study. b Efficiency of conversion of manoyl oxide 
to 11β-hydroxy-manoyl oxide by CYP76AH24 in the different yeast 
strains developed. The efficiency of conversion is calculated as the 
ratio of 11β-hydroxy-manoyl oxide titer to the sum of manoyl oxide 
and 11β-hydroxy-manoyl oxide titres, expressed as percentage
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long enough inside the cell (or in the ER) so as to be effi-
ciently oxidized. This observation may provide important 
insights for future development of CYP-mediated oxida-
tion of terpenes in yeast, as it indicates that efficient chan-
neling of substrates between the terpene synthase step 
and the CYP-mediate oxidation is required.
By combining heterozygous deletions in three yeast 
genes we achieved significant yield improvements. This 
further supports the notion that monoallelic deletions 
can provide a useful genetic engineering tool in cases 
where complete gene deletion may have adverse effects 
in host cell physiology, as is the case here with MCT1 
and GDH1. Further fine-tuning of gene dosage could be 
achieved by complementary approaches, such as the inte-
gration of weaker promoters or destabilizing sequences 
in the mRNA [42].
The yeast platform described in this report opens the 
way for the elucidation of the biosynthesis of the unu-
sual series of tricyclic (8,13)-epoxy-labdanes, providing 
either the starting material for in vitro reactions aiming 
to identify downstream steps of the pathway or a plat-
form for the in vivo screening of candidate biosynthetic 
genes, as previously described for the elucidation of the 
carnosic acid pathway [26]. In addition, 11β-hydroxy-
manoyl oxide produced by this platform can be further 
derivatized by chemical synthesis to yield analogues with 
potentially interesting properties. As already described 
for other terpenes [25], combinatorial biosynthesis 
coupled with protein engineering of labdane skeleton-
acting CYPs can be applied to further derivatize the 
11β-hydroxy-manoyl oxide molecule towards a broad 
range of potentially bioactive compounds.
Methods
Chemicals and enzymes
Standard compounds were obtained from: geranyllinal-
ool (Aldrich, 48809), geranylgeraniol (Sigma, G3278), 
sclareol (VIORYL SA. Athens, Greece). Manoyl oxide 
standard was from our in-house collection, isolated from 
natural sources and characterized by NMR spectros-
copy. PCR amplifications were performed using Phusion 
High-Fidelity DNA Polymerase (New England BioLabs, 
M0530) and MyTaq DNA polymerase (BIO-21105, Bio-
line). Restriction enzymes from New England BioLabs 
were used for cloning purposes. NucleoSpin Plasmid 
Kit (740588, Macherey–Nagel) was used for plasmid 
DNA purification, while QIAquick Gel Extraction Kit 
(#28704, Qiagen) was used for gel extraction and DNA 
purification.
Yeast media, expression vectors, and strains
Yeast cells were cultivated in Complete Minimal (CM) 
medium, composed of 0.13  % (w/v) dropout powder 
(all essential amino acids), 0.67  % (w/v) Yeast Nitrogen 
Base w/o AA (Y2025, US Biologicals) and 2  % d-(+)-
glucose monohydrate (16301, Sigma). For galactose-
based medium, glucose was substituted with 2  % d-(+) 
galactose (G0625, Sigma) and 1  % Raffinose pentahy-
drate (R1030, US Biological). Constructs pYES2myc/
CcCLS-ERG20(F96), pHTDH3myc/SpMilS and pESC-
Leu::CPR2-CYP76AH24 were previously described [25, 
26, 43].
The generation of yeast strain AM119 (Mat a/α, 
PGal1-HMG2(K6R)::HOX2, ura3, trp1, his3, PTDH3-
HMG2(K6R)X2-::leu2 ERG9/erg9, ubc7/UBC7, ssm4/SSM4, 
PTDH3-HEM3-FLO5) has previously been described [26]. 
AM119 was used as the starting strain to generate strain 
AM119-1. Plasmid construct COD7/CcGGDPS (PTDH3-
CcGGDPS-CYC1t, LoxP-HIS5-LoxP) [37], which harbors 
the mature form of C. creticus GGPPS, was PCR amplified 
using primers 5-FLO8-COD7 and 3-FLO8-COD7 (Addi-
tional file  1: Table S1) incorporating flanking sequences 
complementary to the 3′UTR of FLO8 gene. Following 
transformation, selection and excision of the selection 
marker, strain AM119-1 was generated.
The pUG27 cassette [44] was PCR amplified with 
primers MCT1-pUGF and MCT1-pUGR and used to 
transform AM119-1 cells to inactive one allele of MCT1. 
Proper integration of the cassette was verified by PCR on 
genomic DNA of selected colonies using primers MCT-
1prom and MCT1pUGR. Upon excision of the selection 
marker, strain AM119-2 was generated.
To generate strain AM119-3, the pUG27 cassette was 
PCR amplified with primers WHI2-640-pUGF and 
WHI2-2790-pUGR and was used to transform AM119-2 
cells to inactive one allele of WHI2. Proper integration 
of the cassette was verified by PCR on genomic DNA of 
selected colonies using primers WHI2prom and WHI2-
2790-pUGR, followed by selection marker excision.
Strain AM119-3 was subsequently transformed with a 
pUG27 PCR amplified cassette with primers GDH1-F-
646-pUG and GDH1-R-2653 and to inactive one allele of 
GDH. Proper integration of the cassette was verified by 
PCR on genomic DNA of selected colonies using primers 
GDH1prom and GDH1-R-2653 pUG, and the selection 
marker was excised to give rise to strain AM119-4.
Yeast strain cultivation, terpene quantification 
and extraction from yeast cells
Cultivation of yeast cells for the production of terpene 
compounds was performed as previously described [25]. 
For the expression of genes placed under the galactose-
inducible promoters PGAL1 and PGAL10 (the CcCLS-
Erg20p(F96C) fusion, poplar CPR2 and CYP76AH24), 
yeast cultures were grown until OD600 = 0.7–1 and sub-
sequently switched to galactose-raffinose based selective 
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growth medium (10–25  mL). Terpene extraction was 
performed by dodecane overlay (10  %) or liquid–liquid 
extraction using aliquots of 1 ml cultures and pentane as 
extracting solvent. Where appropriate, pentane extracts 
were derivatized using Sylon HTP (hexamethyldisilylaz
ane:trimethylchlorosilane:pyridine, 3:1:9) (Supleco, Bel-
lafonte, PA) as previously described [26]. GC-FID was 
employed for quantification and identification of terpene 
products as described in [45]. Identification of produced 
compounds by GC–MS analysis was carried out by com-
parison with commercial or in-house standards.
Microsomal protein preparation and cytochrome P450 
quantification
Yeast cultures (250 mL) were used to isolate microsomes 
from cells engineered to express CYP76AH24 with the 
method in [46], with an additional final ultracentrifuga-
tion step at 100,000g for 60  min. The concentration of 
CYP76AH24 was determined by the spectroscopic differ-
ence at 450 nm of CYP enzymes due to CO binding [47], 
using the extinction coefficient 91  mM−1  cm−1. Back-
ground correction of the endogenous CYPs was deduced 
using microsomes purified from cells carrying an empty 
vector.
In vitro enzymatic assay and kinetic analysis
The enzymatic activities of CYP76AH24 was evaluated 
as previously described [25] using varying concentra-
tions (1–75 μM) of manoyl oxide as substrate. The enzy-
matic reactions were incubated with shaking at 30  °C 
for 30 min and terminated by extraction with 100 μL of 
decane containg 10 μg/mL sclareol as internal standard. 
2 μL of extracts were analyzed by GC–MS using the con-
ditions previously described [45]. All assays were carried 
out in duplicates.
General experimental procedures relating to the isolation 
and structure elucidation of 11β‑hydroxy‑manoyl oxide
NMR spectra were recorded on Bruker AC 200 and 
Bruker DRX 400 spectrometers. Chemical shifts are 
given on a δ (ppm) scale using TMS as internal stand-
ard. The 2D experiments were performed using standard 
Bruker pulse sequences. Low resolution EI mass spectra 
were measured on either a Hewlett-Packard 5973 mass 
spectrometer or a Thermo Electron Corporation DSQ 
mass spectrometer by using a Direct-Exposure Probe. 
GC–MS analyses were carried out using a Hewlett-
Packard 6890 gas chromatograph equipped with a HP-
5MS fused silica capillary column (30  m  ×  0.25  mm; 
film thickness 0.25  μm), a split-splitless injector and a 
Hewlett-Packard 5973 MS detector operating in electron 
ionization mode at 70 eV. Column chromatography sepa-
rations were performed with Kieselgel 60 (Merck). HPLC 
separations were conducted using an Agilent 1100 Series 
liquid chromatography pump equipped with refractive 
index detector, using a Supelcosil LCSI Semiprep 5  μm 
(250  ×  10  mm i.d.; Supelco) column. TLC were per-
formed with Kieselgel 60 F254 (Merck aluminum support 
plates) and spots were detected after spraying with 15 % 
H2SO4 in MeOH reagent and heating at 100 °C for 1 min.
Isolation of oxidation products
A 1 L culture of AM119 cells expressing the suitable plas-
mid in Gal/Raff-CM medium was overlaid with 100 mL 
of dodecane and incubated in a shake-flask for 2  days. 
The resulting dodecane layer was distilled in vacuo at 
42  °C to afford a concentrated extract (ca. 5  mL) that 
was submitted to gravity column chromatography using 
n-pentane as the mobile phase in order to remove the 
remaining volume of dodecane. The column was flushed 
with EtOAc to retrieve the secondary metabolites. The 
solvent was evaporated in vacuo to yield an oily residue 
(1.07 g) which was submitted to gravity column chroma-
tography on silica gel, using cyclohexane with increasing 
amounts of EtOAc as the mobile phase, to yield 6 frac-
tions (1–6). Fraction 2 (104.0 mg) was subjected to nor-
mal phase HPLC, using cyclohexane/EtOAc (93:7) as 
eluent, to afford a subfraction (41.2 mg) that was further 
purified by normal phase HPLC, using n-Hex/EtOAc 
(94:6) as eluent, to yield 11β-hydroxy-manoyl oxide (4) 
(17.5 mg).
Structure elucidation of isolated compounds
11β-Hydroxy-manoyl oxide (4) was identified on the 
basis of its spectroscopic data and comparison with lit-
erature values [48].
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